Regulators face several challenges in managing chemical risks effectively. The sheer volume of chemicals in commerce, combined with limited resources, makes comprehensive evaluation difficult. Emerging contaminants, such as endocrine disruptors and nanomaterials, pose additional complexities due to their unique properties and potential long-term effects. Balancing economic considerations with public health and environmental protection remains a constant challenge for regulatory bodies.
